Literature DB >> 22926609

Suspected and confirmed fatalities associated with mephedrone (4-methylmethcathinone, "meow meow") in the United Kingdom.

Fabrizio Schifano1, John Corkery, A Hamid Ghodse.   

Abstract

BACKGROUND: International media have been reporting about fatalities allegedly related to mephedrone, a popular recreational stimulant, but now a proportion of them have been confirmed. We aimed here at analyzing information relating to the circumstances of mephedrone-related deaths in the United Kingdom.
METHODS: Descriptive analysis of information was mainly extracted from the UK National Programme on Substance Abuse Deaths database. With an average annual response rate of 95%, UK National Programme on Substance Abuse Deaths receives information from coroners on drug-related deaths among both addicts and nonaddicts in the United Kingdom, the Channel Islands, and the Isle of Man.
RESULTS: So far, 128 alleged mephedrone-associated fatalities have been reported; mephedrone was identified at postmortem in 90 cases; inquests have been concluded in 69 cases, 62 of which are analyzed here. Typical mephedrone victims were young (mean age, 28.8 years), male, and with a previous history of drug misuse. There was a notable number (18 cases [29%], 11 being from hanging) of deaths involving self-harm. Mephedrone alone was identified at postmortem on 8 occasions (13% of the inquests' sample).
CONCLUSIONS: Present mortality data may suggest a significant level of caution when ingesting mephedrone. Limitations include an inability to determine the exact extent of risks associated with mephedrone consumption.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926609     DOI: 10.1097/JCP.0b013e318266c70c

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  25 in total

Review 1.  Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

Authors:  Christopher L German; Annette E Fleckenstein; Glen R Hanson
Journal:  Life Sci       Date:  2013-08-02       Impact factor: 5.037

Review 2.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

3.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

4.  Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications.

Authors:  Fabio De-Giorgio; Sabrine Bilel; Andrea Ossato; Micaela Tirri; Raffaella Arfè; Federica Foti; Giovanni Serpelloni; Paolo Frisoni; Margherita Neri; Matteo Marti
Journal:  Int J Legal Med       Date:  2019-06-01       Impact factor: 2.686

Review 5.  New psychoactive substances: Pharmacology influencing UK practice, policy and the law.

Authors:  David Nutt
Journal:  Br J Clin Pharmacol       Date:  2020-02-04       Impact factor: 4.335

6.  Acute Methylenedioxypyrovalerone Toxicity.

Authors:  Blake A Froberg; Michael Levine; Michael C Beuhler; Bryan S Judge; Philip W Moore; Kristin M Engebretsen; Nathanael J Mckeown; Christopher D Rosenbaum; Amy C Young; Daniel E Rusyniak
Journal:  J Med Toxicol       Date:  2015-06

7.  Human Pharmacology of Mephedrone in Comparison with MDMA.

Authors:  Esther Papaseit; Clara Pérez-Mañá; Julián-Andrés Mateus; Mitona Pujadas; Francina Fonseca; Marta Torrens; Eulàlia Olesti; Rafael de la Torre; Magí Farré
Journal:  Neuropsychopharmacology       Date:  2016-05-20       Impact factor: 7.853

Review 8.  Synthetic cathinone adulteration of illegal drugs.

Authors:  Chicora F Oliver; Joseph J Palamar; Alberto Salomone; Steven J Simmons; Helene L Philogene-Khalid; Nick Stokes-McCloskey; Scott M Rawls
Journal:  Psychopharmacology (Berl)       Date:  2018-10-18       Impact factor: 4.530

Review 9.  Effects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicals.

Authors:  Nicolas Hohmann; Gerd Mikus; David Czock
Journal:  Dtsch Arztebl Int       Date:  2014-02-28       Impact factor: 5.594

10.  The clinical challenges of synthetic cathinones.

Authors:  Fabrizio Schifano; Flavia Napoletano; Davide Arillotta; Caroline Zangani; Liam Gilgar; Amira Guirguis; John Martin Corkery; Alessandro Vento
Journal:  Br J Clin Pharmacol       Date:  2020-02-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.